Microfluidic biochip detection device and use method

By separating and placing the blood reagent unit from the biochip unit and flexibly assembled, the problem of limited and wasteful reagents in the existing microflower biochip detection device is solved, and the reagents and chips are flexibly selected, saving space and cost, and improving detection is achieved. Efficiency and flexibility.

CN117696134BInactive Publication Date: 2024-11-22TAIWAN BIOCHIPLET MEDICAL AI CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311448340.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2023-05-08
Filing Date
2023-11-02
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing micro-flower biochip detection device has limited types of reagents on the blood micro-flower, and the types of blood components detected are also limited, and the frequency of different reagents is used differently, resulting in waste. When the reagents on a certain micro-flower are exhausted or damaged. The specific blood components cannot be detected normally, causing the entire device to fail.

Method used

Place the blood reagent unit and the biochip unit separately, and can be combined or separated from each other. Select the corresponding reagent and chip as needed to assemble it into the required microflower detection device. Blood and detection liquid flow through different microflowers to the biological system respectively. Chips that reduce liquid interference, allow vertical stacking of multiple microflowers, simplify structure and improve elasticity.

Benefits of technology

It realizes flexible selection of reagents and chips as needed, saves space, reduces waste and repair costs, improves detection flexibility and efficiency, and avoids device failure caused by reagent depletion or damage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117696134B_ABST
    Figure CN117696134B_ABST
Patent Text Reader

Abstract

The present invention provides a microfluidic biochip detection device and a method of use. The microfluidic biochip has a blood reagent unit and a biochip unit that are interconnected. In the blood reagent unit, blood flows through a microchannel with a reagent so that a certain blood special component reacts with the reagent. In the biochip unit, the detection liquid and the blood from the blood reagent unit flow through different microchannels and react with the biochip respectively. By comparing the different reaction data obtained when the biochip reacts with the detection liquid before and after the reaction with the blood, information about the special components of the blood can be obtained. According to the special blood components that need to be detected, a blood reagent unit with a suitable reagent and a biochip unit with a suitable biochip can be selected to form a microfluidic biochip detection device.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to U.S. Provisional Patent Application No. 63 / 500,647, filed on May 8, 2023, the disclosure of which is incorporated herein by reference in its entirety. Technical Field

[0003] The present invention relates to a microfluidic biochip detection device and a method of use, in particular, placing reagents that react with blood components and biochips that react with detection fluid and blood in a blood reagent unit and a biochip unit respectively, thereby increasing the flexibility of use and reducing the overall cost. Background Art

[0004] Blood tests can provide important information about the human body's condition, but traditional hospital blood tests are often time-consuming and labor-intensive and cannot provide real-time and effective information. Therefore, in recent years, the use of micro-electro-mechanical systems (MEMS) to form miniaturized detection devices on substrates has become a hot field. In this way, compared with traditional blood tests, the amount of blood sample and reagent required are smaller, the reaction speed is faster, and the accuracy is higher. In particular, reagents or microstructures that can capture and concentrate antibodies, antigens, proteins and other components in specific blood cells or plasma can be designed for different diseases and different blood components to be tested, that is, various chips can be customized. There are many specific designs and development methods for biochips. For some introductory introductions, you can refer to the National Taiwan University Electrical Science Series: https: / / ee.ntu.edu.tw / upload / hischool / doc / 2013.11.pdf or the 29th volume and 2nd issue of Scientific Knowledge: https: / / www.tiri.narl.org.tw / Files / Doc / Publication / InstTdy / 160 / 01600670.pdf.

[0005] In recent years, along with the development of semiconductor technology and microfluidic technology, a common microfluidic biochip detection device is a biochip and a microfluidic channel placed on the same substrate at the same time, any microfluidic channel has an opening adjacent to the biochip and another opening for fluid to enter, and one or more microfluidic channels have one or more reagents. In this way, the blood to be tested will first interact with the reagent when flowing through the microfluidic channel, and then reach the biochip and interact with the biochip to change the state of the biochip. For example, the red blood cells in the blood to be tested will first be solidified and precipitated by the red blood cell precipitant in the microfluidic channel, and then the treated blood to be tested will contact the biochip. At this time, the miniaturized detection device on the biochip (such as a microelectrode or a microstick with many reactive groups on the surface, etc.) will interact with the blood to be tested that has lost at least a part of the red blood cells (such as mutual binding and loss of reactivity). In addition, the detection liquid will flow through the microfluidic channel without reagents and reach the biochip. Before and after the biochip contacts the blood, the interaction between the detection liquid and the biochip will generate two sets of different data respectively. By comparing these two sets of data, the test results of the blood to be tested can be obtained (or the results of the interaction between the blood and the reagent can be inferred).

[0006] However, this common design still has some problems, although it has the advantages of simple process and not prone to liquid leakage. Since the biochip, the microfluidic channel for the test liquid and the microfluidic channel for blood with reagents are all on the same substrate, if there are not many types of reagents on the microfluidic channel for blood, the types of blood components that can be detected are limited, and if there are more than one reagent on the same microfluidic channel for blood, their effects on the blood to be tested will inevitably interfere with each other. Therefore, a common design is that there are multiple microfluidic channels for blood on the same substrate and each microfluidic channel has only one reagent. However, such a design, in addition to the problem of large substrate area occupied by the increase in the number of microfluidic channels, there is also a waste problem caused by different frequencies of use of different reagents (or different probabilities of different types of blood test items). After all, if the reagent on a microfluidic channel for blood has been exhausted or damaged and cannot normally detect a specific component in the blood, the entire microfluidic biochip detection device can no longer be used to detect this specific component in the blood.

[0007] Obviously, there is a need to improve the existing microfluidic biochip detection device so as to more efficiently utilize the existing biochip. Summary of the invention

[0008] The present invention proposes a microfluidic biochip detection device and a method for using the same. The basic concept of the present invention is to place the blood microfluidic channel where the reagent is located and the biochip used to interact with the detection liquid and blood respectively on two hardwares, and allow the two hardwares to be combined with each other or separated from each other. In this way, according to which special component or components in the blood need to be detected, the hardware of the blood microfluidic channel with the corresponding special reagent and the hardware of the corresponding special biochip can be selected first, and then the two hardwares can be combined with each other to form the required microfluidic biochip detection device. Then, the detection liquid, blood and detection liquid are sequentially input into this microfluidic biochip detection device, and then the two sets of data obtained by the reaction of the biochip and the detection liquid before and after the contact between the blood and the biochip are compared, so that the detection of the special components in the blood to be detected can be completed.

[0009] According to the basic concept of the present invention, the present invention proposes a microfluidic biochip detection device, which has a blood reagent unit and a biochip unit. Here, the blood reagent unit has a first opening, a second opening and a first microfluidic channel. The blood entering the blood reagent unit from the first opening will first flow through the first microfluidic channel located inside the blood reagent unit, and then flow out of the blood reagent unit from the second opening. Here, the biochip unit has a third opening, a fourth opening, a second microfluidic channel, a third microfluidic channel and a biochip. The blood from the blood reagent unit entering the biochip unit from the third opening will flow through the second microfluidic channel located inside the biochip unit and reach the biochip located inside the biochip unit, and the detection liquid entering the biochip unit from the fourth opening will flow through the third microfluidic channel located inside the biochip unit and reach the biochip. In addition, at least one reagent is located in the first microfluidic channel to react with a certain component flowing through the blood. Moreover, the second microfluidic channel and the third microfluidic channel are separated from each other, so that the blood and the detection liquid flow to the biochip separately.

[0010] Obviously, compared with the prior art, the microfluidic biochip detection device proposed by the present invention changes the relative relationship between the hardware for processing blood and the hardware for using the biochip, and also changes the relative relationship between the microfluidic channel through which blood flows and the microfluidic channel through which the detection liquid flows and the biochip, but the reagents and biochips of the prior art can be directly used. The conventional technology is to place all microfluidic channels and biochips on the same plane (the surface of the same substrate), which inevitably leads to the problem that the number of microfluidic channels (or the number of microfluidic channel openings) near the same biochip that can allow blood / detection liquid to flow to the biochip is limited. In contrast, the present invention allows the blood and test fluid flowing through different microchannels to flow to the biochip separately, that is, different microchannels and biochips are arranged separately (for example, each microchannel is arranged on the left, right, upper side, upper side or even perpendicular to each other of the biochip). This not only saves the occupied area (such as the area occupied by the medical testing workbench), but also allows the number of microchannels corresponding to the same biochip to be unlimited (for example, multiple microchannels can be stacked vertically upwards), and allows different microchannels to be completely separated to minimize the possibility of interference between different liquids (reducing the accidental situation of reaching other microchannel openings from a microchannel opening of an adjacent biochip due to movement inertia, etc.).

[0011] In particular, compared with the prior art, the microfluidic biochip detection device proposed by the present invention separates the part related to blood flow and reagents and the part related to the detection liquid and biochip into two parts. Therefore, the present invention can also allow the blood reagent unit and the biochip unit to be detachably connected to each other. In other words, the same biochip unit can be combined with multiple different blood reagent units (such as different blood reagent units with different reagents) at different times and occasions, as long as the blood from the blood reagent unit that has been treated with reagents can flow smoothly into the biochip unit at each combination. Of course, when these two units are connected to each other, they should be tightly combined without leaking blood, that is, the second opening of the blood reagent unit is connected to the third opening of the biochip unit, so that the blood will not leak out of the two units during the process of flowing from the blood reagent unit to the biochip unit. Obviously, by using the microfluidic biochip detection device proposed by the present invention, different blood reagent units can be used to combine with the biochip unit for detection when different components of blood need to be detected (or when different reagents need to be used to treat blood). In this way, the structure of the blood reagent unit can be simplified to the point where each blood reagent unit contains only a few or even only one reagent. This eliminates the need to excessively increase the thickness of the entire microfluidic biochip detection device due to the continued increase in the types of reagents that may be used, and also increases the flexibility of the actual use of the microfluidic biochip detection device, because only the required blood reagent unit needs to be selected as needed.

[0012] The specific mechanism design of the blood reagent unit and the biochip unit does not need to be limited, and there are many possible changes. Generally speaking, in order to facilitate user operation and assist the flow of blood and test liquid, and to ensure the smooth circulation of blood, the second opening is adjacent to the third opening, the first opening and the fourth opening are located on the same side of the microfluidic biochip detection device, and the first opening and the fourth opening are located on the opposite sides of the microfluidic biochip detection device with the biochip. In addition, in order to reduce the impact of impurities on the biochip, a first filter can be placed at the first opening to filter impurities in the blood sample at the beginning, and a second filter can be placed between the second opening and the third opening to filter impurities in the blood generated when the blood and the reagent react with each other. Further, the first microchannel can have only a part of a certain reagent or different reagents can be respectively provided in different parts, and any reagent can be used to react with a certain component of the blood, that is, different reagents can be used to react differently with a certain component of the blood, or different components in the blood. In addition, the type of reagent and how the reagent is placed in the microchannel can directly use the existing technology. For example, at least one reagent may be coated on the first microfluidic channel, and possible types of reagents include but are not limited to the following: separation agent, red blood cell precipitant, white blood cell precipitant, activated carbon and silver nitrate.

[0013] For example, one design is that the blood reagent unit is a double-layer structure composed of a first layer and a second layer arranged in sequence, wherein the first opening is located in the first layer, and the second opening and the first microchannel are located in the second layer. That is, the interface with the outside world is in the first layer, and the rest are in the second layer, such as different reagents are located in different parts of the second layer. Another design is that the blood reagent unit is a three-layer structure composed of a first layer, a third layer, and a fourth layer arranged in sequence, wherein the first opening is located in the first layer, the second opening is located in the third layer, and the first microchannel is located in the third and fourth layers. That is, the interface with the outside world is in one layer, the interface with the biochip unit is in another layer, and different reagents are located in different parts of the two layers that are not interfaces with the outside world, so that there is more space to arrange the first microchannel and reagents. Furthermore, another design is that the blood reagent unit is a three-layer structure composed of a first layer, a third layer and a fourth layer arranged in sequence, wherein the first opening is located in the first layer, the second opening is located in the third layer, the first microchannel is located in the fourth layer, the third layer further includes a first groove and a second groove, and the first microchannel is connected to the first groove and the second groove respectively, so that at least one reagent is located in the first microchannel between the first groove and the second groove. That is, the interface with the outside world is in one layer, the interface with the biochip unit is in another layer, and different reagents are located in different parts of the two layers that are not the outside interface, so that there is more space to arrange the first microchannel and the reagent, and there are two grooves that can provide a buffer function similar to a reservoir at the place where the blood just enters and the place where the blood will leave, so as to ensure the stable and continuous flow of blood.

[0014] For example, one design is that the biochip unit is a double-layer structure composed of the fifth layer and the sixth layer arranged in sequence, wherein the fourth opening is located on the fifth layer, the third opening is located on the sixth layer, the second microchannel and the third microchannel are both located on the sixth layer, and the biochip is located at the bottom of the sixth layer. That is, the interface with the outside world is on one layer, and the different microchannels and the biochip are on another layer, thereby simplifying the relevant structure. Another design is that the biochip unit is a three-layer structure composed of the fifth layer, the seventh layer and the eighth layer arranged in sequence, wherein the fourth opening is located on the fifth layer, the third opening and the second microchannel are located on the seventh layer, the third microchannel is located on the eighth layer, and the biochip is located at the bottom of the eighth layer. That is, the microchannel through which the blood flows and the microchannel through which the detection liquid flows are more clearly arranged in layers, so that the process of blood and detection liquid flowing to the biochip separately will not interfere with each other. Another design is that the biochip unit is a three-layer structure consisting of the fifth layer, the seventh layer and the eighth layer arranged in sequence, wherein the fourth opening is located on the fifth layer, the third opening and the second microchannel are located on the seventh layer, the third microchannel is located on the eighth layer and first passes through the third groove located on the eighth layer before reaching the vicinity of the biochip, and the biochip is located at the bottom of the eighth layer. That is, in addition to arranging the microchannels through which the blood flows and the microchannels through which the detection liquid flows in layers, the grooves are used to provide a buffer function similar to a reservoir after the detection liquid enters and before it reaches the biochip, thereby ensuring the stable and continuous flow of the detection liquid.

[0015] In addition, in order to assist the liquid to flow through the microchannel and reduce the liquid flow obstruction caused by the bending of the microchannel (whether it is bending in the horizontal direction or the vertical direction) or even because of the reagent in the microchannel or the outline size of the cross section of the microchannel, a gas pump can be used to continuously input gas into one or more microchannels to assist in pushing the liquid. For example, the blood reagent unit can include a first gas opening and a first gas microchannel, and the gas entering from the first gas opening will flow through the first gas microchannel and enter the first microchannel, thereby promoting the flow of blood. For example, the biochip unit can include a second gas opening and a second gas microchannel, and the gas entering from the second gas opening will flow through the second gas microchannel and enter the third microchannel, thereby promoting the flow of the test liquid. Here, the first gas opening and the second gas opening can be connected to a gas pump, a gas cylinder or other gas source to receive gas with a pressure sufficient to push the liquid to flow through the microchannel.

[0016] Incidentally, since the test liquid and blood will flow to the biochip separately, if they are not properly unblocked, they will accumulate on the biochip and affect the subsequent operation of the biochip. Therefore, a waste liquid tank and a waste liquid discharge hole can be arranged at the bottom of the biochip unit, wherein the waste liquid tank is connected to the biochip to temporarily store the blood and test liquid flowing through the biochip, and the waste liquid discharge hole is connected to the waste liquid tank to discharge the blood and test liquid from the waste liquid tank to leave the microfluidic biochip detection device.

[0017] According to the basic concept of the present invention, the present invention proposes a method for detecting blood using a microfluidic biochip detection device, which has the following basic steps. First, the special components of the blood are detected as needed, and the special reagents, special detection liquids and special biochips that need to be used are determined. Secondly, a microfluidic biochip detection device with special reagents and special biochips is provided. Next, the special detection liquid is input into the microfluidic biochip detection device to obtain first reaction data of the special detection liquid and the special biochip. Then, blood is input into the microfluidic biochip detection device so that the special biochip interacts with the blood treated with the special reagent to change the state of the special biochip. Next, the special detection liquid is input into the microfluidic biochip detection device again to obtain second reaction data of the special detection liquid and the special biochip with the changed state. Finally, the first reaction data and the second reaction data are compared to determine the status of the special components of the blood.

[0018] Obviously, compared to the microfluidic biochip detection device that uses conventional technology to integrate multiple microchannels / reagents on the same flat plate, a major feature of the present invention is that the corresponding reagents and biochips can be selected according to the components in the blood that need to be detected, and then assembled into the required microfluidic biochip detection device. Next, just like the previous technology, the detection liquid, blood and detection liquid are allowed to flow through the biochip in sequence, and the condition of the blood is judged by comparing the data obtained from the reaction of the biochip and blood before and after the condition of the biochip is changed by the blood.

[0019] Therefore, after testing the previous batch of blood and before testing the next batch of blood, if the first special component to be tested in the previous batch of blood is different from the second special component to be tested in the second batch of blood, or even if the two batches of blood are to be tested differently for the same special component, the corresponding blood reagent unit and biochip unit can be selected according to the second special component of the second batch of blood or even according to the different tests to be performed on the same special component, and assembled into a microfluidic biochip detection device different from the previously used one. Next, the special detection liquid is input into the biochip unit, the blood is input into the blood reagent unit, and the special detection liquid is input into the biochip unit in sequence, and then the first reaction data and the second reaction data obtained are compared to determine the status of the second special component or the different test results of the same special component.

[0020] Since the method proposed in the present invention uses the microfluidic biochip detection device proposed in the present invention, the various changes of the related microfluidic biochip detection device are as described above and do not need to be repeated here.

[0021] The advantages of the present invention compared to the prior art are obvious. Since the blood reagent unit and the biochip unit can be combined or separated from each other. Therefore, according to the blood components to be detected or the blood test items to be performed, the blood reagent unit and the biochip unit with the required reagents and the required biochip can be selected and assembled into a microfluidic biochip detection device. That is, it can be realized by selecting and using the required units like building blocks, and the use flexibility is high. The medical site only needs to prepare various blood reagent units and biochip units, and the medical staff can assemble the microfluidic biochip detection device by themselves as needed. In addition, the conventional technology requires that a variety of reagents, microchannels and biochips that may be used be assembled into a single microfluidic biochip detection device in advance, and it is inevitable that when a certain reagent has been used up by the reaction of the blood flowing through it, a certain microchannel is blocked by impurities in the blood, or even when the biochip is out of condition, the entire microfluidic biochip detection device cannot operate normally, resulting in low efficiency and high use cost that requires the entire repair or even the entire scrapping. In contrast, the present invention can simply remove the problematic unit and replace it with a new unit, which not only reduces the cost of waste and scrapping, but also simplifies the cost of maintenance. For example, when a specific reagent in the blood reagent unit has been used up, the blood reagent unit can be directly removed and another blood reagent unit with sufficient specific reagent can be used to combine with the biochip unit to form the required microfluidic biochip detection device, so that the biochip unit part will not be affected at all. In addition, since the blood and the detection liquid flow to the biochip through different microfluidic channels respectively, the possibility of arranging a plurality of microfluidic channels vertically allows the number of microfluidic channels corresponding to the same biochip to be basically unlimited, as long as the blood and the detection liquid can flow from the microfluidic channel to the biochip appropriately (such as dripping from the microfluidic channel opening to the biochip appropriately). In this way, the blood reagent unit can be expanded to have a plurality of microfluidic channels at the same time to correspond to different reagents or different blood to be detected, and the biochip unit can also be expanded to have a plurality of microfluidic channels at the same time to correspond to a plurality of blood from the blood reagent unit or even a variety of different detection liquids. It should be emphasized that in the conventional technology, since all microfluidic channels and biochips are on the same plate (the same plane), the area and contour of the biochip limit the upper limit of the number of microfluidic channels that can be matched. Incidentally, although the conventional technology has the advantages of simple process and less leakage of blood or test fluid by putting everything on the same plate, since it is a common commercial technology to connect hardware components like building blocks and prevent liquid leakage by applying pressure, using laser fusion or using O-rings, the present invention has no technical difficulties in practical application. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] The above and other features, advantages and aspects of the embodiments of the present invention will become more apparent with reference to the following detailed description in conjunction with the accompanying drawings. In the accompanying drawings, the same or similar reference numerals represent the same or similar elements.

[0023] Figures 1A to 1D The microfluidic biochip detection device proposed in the present invention is shown.

[0024] FIG. 2A to FIG. 2E A specific design of the microfluidic biochip detection device proposed in the present invention is shown.

[0025] FIG. 3A to FIG. 3D The method of using the microfluidic biochip detection device proposed by the present invention is shown. DETAILED DESCRIPTION

[0026] The following content describes the present invention and some preferred embodiments for those skilled in the art to understand the features of the present invention. Although preferred embodiments of the present invention are shown in the accompanying drawings, it should be understood that the present invention can be implemented in various forms and should not be limited by the embodiments described herein. On the contrary, these embodiments are provided to make the present invention more thorough and complete, and to fully convey the scope of the present invention to those skilled in the art.

[0027] As used herein, the term "including" and its variations mean open inclusion, i.e., "including but not limited to". Unless otherwise stated, the term "or" means "and / or". The term "based on" means "based at least in part on". The terms "an example embodiment" and "an embodiment" mean "at least one example embodiment". The term "another embodiment" means "at least one additional embodiment". The terms "first", "second", etc. may refer to different or the same objects.

[0028] Figure 1A The basic structure of the microfluidic biochip detection device proposed by the present invention is shown. Figure 1AAs shown, the microfluidic biochip detection device 100 includes two parts: a blood reagent unit 101 and a biochip unit 102. The former has a first microfluidic channel 1011 through which blood can flow and a reagent 1012 located in the first microfluidic channel 1011, and the latter has a second microfluidic channel 1021 through which blood can flow, a third microfluidic channel 1022 through which a detection liquid can flow, and a biochip 1023. When the blood reagent unit 101 and the biochip unit 102 are connected, the first microfluidic channel 1011 is connected to the second microfluidic channel 1021 so that blood can enter the biochip unit 102 from the blood reagent unit 101. Moreover, both the second microfluidic channel 1021 and the third microfluidic channel 1022 have openings in the part adjacent to the biochip 1023, so that blood and the detection liquid can flow to the biochip 1023 through the corresponding openings and react with the biochip 1023. Thereby, the blood can first react with the reagent 1012 in the blood reagent unit 101 before contacting the biochip 1023 and reacting, and the blood and the detection liquid can be separately transferred to the biochip 1023 and react.

[0029] Furthermore, in order to facilitate the flow of blood and the test liquid to the biochip 1023, and also to facilitate the application of blood and the test liquid to the microfluidic biochip detection device 100, a common structure of the microfluidic biochip detection device proposed by the present invention is as follows: Figure 1B As shown, the first opening 1013 through which blood enters the blood reagent unit 101 and the second opening 1024 through which the test liquid enters the biochip unit 102 are both located on the same side of the microfluidic biochip test device, and the biochip 1023 is located on the opposite side of the microfluidic biochip test device 100. By having the first opening 1013 and the second opening 1024 both located at the top, the operator of the microfluidic biochip test device 100 can simply apply blood and the test liquid, and the blood and the test liquid also flow from top to bottom toward the biochip 1023, making it easy to configure the first microfluidic channel 1011, the second microfluidic channel 1021, and the third microfluidic channel 1022. Of course, purely in terms of the basic structure of the present invention, the first opening 1013 and the second opening 1024 can be located on different surfaces of the microfluidic biochip test device 100, as long as the user can apply blood and the test liquid. Furthermore, the first opening 1013 and / or the second opening 1024 do not necessarily have to be located at two opposite sides of the microfluidic biochip detection device 100 from the biochip 1023 , as long as the blood and the detection liquid can flow and reach the biochip 1023 .

[0030] Obviously, the present invention only requires that the blood does not leak out during the process of blood flowing from the blood reagent unit 101 to the biochip unit 102, and does not need to restrict the contour, size, shape and internal configuration of the blood reagent unit 101 and the biochip unit 102. For example, Figure 1A The blood reagent unit 101 and the biochip unit 102 are shown to have the same size and profile, but the distribution of the microchannels inside the two is different (ignoring that the biochip 1023 is only present in the biochip unit 102). For example, Figure 1B The blood reagent unit 101 is shown to be smaller in size and the biochip unit 102 is shown to be larger in size. After all, the second microchannel 1021, the third microchannel 1022 and the biochip 1023 need to be separately placed inside the biochip 1023. Compared with the blood reagent unit 101, which only needs to place the first microchannel 1011, if the biochip unit 102 is larger in size, there will be more space to arrange. Of course, although not specifically shown in the figure, as long as the adjacent surfaces of the two units remain unchanged or as long as the microchannels required for blood flow between the two units can be connected, the contours, sizes and internal structures of the two units can have other various changes. For example, the blood reagent unit 101 and the biochip unit 102 can both have a multi-layer structure, and the first opening 1013 for blood to enter, the second opening 1024 for the detection liquid to enter, the three microchannels 1011 / 1021 / 1022 and the biochip 1023 can be located in the same layer or in different layers, that is, the internal configuration of each can be adjusted as needed. For example, the first opening 1013 and the second opening 1024 for blood and test fluid to enter can be located in the same layer, while the microchannels 1011 / 1021 / 1022 can be located in other layers. For another example, the microchannels 1011 / 1021 / 1022 can be located in the same layer or in different layers with the biochip 1023, or even when a microchannel is long enough (such as the first microchannel 1011 that needs to be arranged to place multiple reagents 1012), different parts of the microchannel can be located in different layers. For example, there can be multiple first microchannels 1011 inside the blood reagent unit 101, each with the same or different reagents 1012, so that the same test can be performed on different blood samples or different tests (detecting different blood components) can be performed on the same or different blood samples in the same blood reagent unit 101. Of course, the number of second microchannels 1021 inside the biochip unit 102 also needs to be increased accordingly. For example, the same first microchannel 1011 can have more than one reagent 1012, that is, more than one test can be performed on the same blood sample. Figure 1A and Figure 1BAs shown, as long as blood and test fluid can flow from the second microchannel 1021 and the third microchannel 1022 to the biochip 1023 respectively, for any microchannel, the opening for allowing blood or test fluid to leave and go to the biochip 1023 can be at its end or far away from its end.

[0031] In addition, to ensure the flow of blood and / or test fluid, such as Figure 1C and Figure 1D As shown, the blood reagent unit 101 further includes a first gas opening 1014 and a first gas microchannel 1015. The gas entering from the first gas opening 1014 will flow through the first gas microchannel 1015 and enter the first microchannel 1011, thereby promoting the flow of blood. In contrast, the biochip unit 102 further includes a second gas opening 1025 and a second gas microchannel 1026. The gas entering from the second gas opening 1025 will flow through the second gas microchannel 1026 and enter the third microchannel 1022, thereby promoting the flow of the test liquid. Of course, although not specifically shown in the figure, it is also possible that the biochip unit 102 has another set of gas openings and gas microchannels for receiving gas to promote the flow of blood in the second microchannel 1021. Generally speaking, the first gas opening 1014 and the second gas opening 1025 can be connected to a gas pump, a gas cylinder or other gas sources to continuously receive gas, especially nitrogen or inert gas with low reactivity that will hardly affect the properties of blood and test fluid.

[0032] Furthermore, in order to process the blood and the test liquid flowing to the biochip 1023, especially to prevent the blood and the test liquid flowing to the biochip 1023 from interfering with each other and affecting the normal operation of the biochip 1023, although the relevant details are not specifically shown, the bottom of the biochip unit 102 further includes a waste liquid tank and a waste liquid discharge hole. The waste liquid tank is connected to the biochip 1023 to temporarily store the blood and the test liquid flowing through the biochip 1023, and the waste liquid discharge hole is connected to the waste liquid tank to discharge the blood and the test liquid from the waste liquid tank (discharged from the biochip unit 102). Incidentally, although it is not specifically shown, at the opening of the first microchannel 1011 near the shell of the blood reagent unit 101, or at the opening of the second microchannel 1021 near the shell of the biochip, an O-ring can be placed or laser fusion can be used to collect and / or mechanically pressurize to prevent the accidental blood leakage when the two units are combined with each other.

[0033] As an example of the microfluidic biochip detection device proposed in the present invention, Figures 2A to 2E Here, the microfluidic biochip detection device 200 includes a blood reagent unit 201 and a biochip unit 202, the former having a smaller area and depth, and the latter having a larger area and depth. Figure 2A and Figure 2B As shown, from the top and from a certain side, the blood reagent unit 201 and the biochip unit 202 are respectively located in different parts of the entire microfluidic biochip detection device 200, but from the bottom and from another side, the blood reagent unit 201 is located on the biochip unit 202, or in other words, the overall outline of the biochip unit 202 is similar to a step-like structure and the blood reagent unit 201 is located on this step-like structure. In this way, the biochip unit 202 has more space to arrange the space configuration of the microfluidic channel through which the blood flows, the microfluidic channel through which the detection liquid flows, and the biochip.

[0034] like Figure 2CAs shown, the blood reagent unit 201 is a three-layer structure, the top layer only has the first opening 2011 and the second opening 2012 for blood and gas to enter respectively, the middle layer has the first groove 2013 and the second groove 2014 separated from each other, and the bottom layer has the blood microchannel 2015, whose two ends are respectively located below the bottom opening of the first groove 2013 and the bottom opening of the second groove 2014. The first groove 2013 is connected to the two openings 2011 / 2012 at the same time to receive blood and gas input from the outside. The blood entering the first groove 2013 will first enter the blood microchannel 2015 through its bottom opening and then enter the second groove 2014 through the bottom opening of the second groove 2014. One or more reagents located in the blood microchannel 2015, or even one or more reagents located in the first groove 2013 and / or the second groove 2014, can interact with one or more components of the blood when the blood flows through. The blood treated with the reagent that leaves the second groove 2014 will flow out of the blood reagent unit 201 from the third opening 2016 and go to the biochip unit 202. There is an O-ring 2017 (only the method of using the O-ring is shown here without showing other possible methods) at the place where the blood reagent unit 201 shell is adjacent to the third opening 2016, which is used to prevent abnormal leakage of blood between the blood reagent unit 201 and the biochip unit 202. Here, the first groove 2013 and the second groove 2014 can be used to regulate the flow of stable blood, and can also provide a buffer space for blood and reagents to fully interact or even provide a space for placing one or more reagents. In some related but not particularly illustrated variations, the first groove 2013 and / or the second groove 2014 can have a larger area and a deeper depth, but can also have a cross-sectional profile and cross-sectional size comparable to the blood microchannel 2015, depending on whether the blood can flow smoothly from the first opening 2011 to the third opening 2016. Similarly, although the blood microchannel 2015 shown in the current figure is only a straight groove with two ends located below the first groove 2013 and the second groove 2014, in some related but not particularly illustrated variations, the blood microchannel 2015 can also be distributed in a winding manner at the bottom layer, as long as it can receive blood from the first groove 2013 and allow blood to enter the second groove 2014. Even if the blood microchannel 2015 is to place reagents to react with blood, in some related but not particularly illustrated variations, part of the blood microchannel 2015 can also be located in the middle layer, that is, the openings of the first groove 2013 and / or the second groove 2014 are not located at the bottom but at the side thereof.

[0035] like Figure 2DAs shown, the biochip unit 202 is also a three-layer structure, the top layer only has the fourth opening 2021 and the fifth opening 2022 for the detection liquid and the gas to enter respectively, the middle layer has the blood microchannel 2023, and the bottom layer has the detection liquid microchannel 2024 and the third groove 2025, and there is also a biochip 2026 at the bottom of the bottom layer. The blood microchannel 2023 is connected to the third opening 2016 of the blood reagent unit 201, and it has an opening near the biochip 2026, so that the blood treated by the reagent from the blood reagent unit 201 can flow from this opening to the biochip 2026. The third groove 2025 is connected to the two openings 2021 / 2022 to receive the detection liquid and gas input from the outside. Obviously, the third groove 2025 can be used to adjust the flow of the stable detection liquid. In some related but not particularly illustrated variations, the third groove 2025 may have a larger area and a deeper depth, but may also have a cross-sectional profile and cross-sectional dimensions comparable to those of the detection liquid microchannel 2024, depending on whether the detection liquid can smoothly flow from the fourth opening 2021 to the top of the biochip 2026. Similarly, the detection liquid microchannel 2024 also has an opening near the biochip 2026, so that the detection liquid can flow from this opening to the biochip 2026. Here, since the blood microchannel 2023 and the detection liquid microchannel 2024 only need to allow the blood and the detection liquid to flow smoothly to the top of the biochip 2026, the distribution (or profile) of the two can be just simple lines, as long as the two are separated from each other to ensure that the blood and the detection liquid can contact the biochip 2026 respectively. Furthermore, at the bottom of the bottom layer, the biochip 2026 can receive the blood and test fluid flowing thereto, and near the biochip 2026 of the bottom layer, there can be an area for placing a waste liquid tank and a waste liquid discharge hole, such as Figure 2E The processing area 2027 is shown. Here, since there are many conventional technologies for storing and removing liquids (blood and test fluid), such as a combination of a large groove, some microchannels and one or more openings, the relevant details do not need to be particularly illustrated.

[0036] Figure 3AThe method for detecting blood using a microfluidic biochip detection device proposed by the present invention is shown, which includes the following basic steps. First, as shown in step block 301, the special components of the blood are detected as needed, and the special reagents, special detection liquids and special biochips to be used are determined. Secondly, as shown in step block 302, a microfluidic biochip detection device with special reagents and special biochips is provided. Furthermore, as shown in step block 303, the special detection liquid is input into the microfluidic biochip detection device to obtain the first reaction data of the special detection liquid and the special biochip. Then, as shown in step block 304, blood is input into the microfluidic biochip detection device so that the special biochip interacts with the blood treated with the special reagent to change the state of the special biochip. Next, as shown in step block 305, the special detection liquid is input into the microfluidic biochip detection device again to obtain the second reaction data of the special detection liquid and the special biochip with the changed state. Finally, as shown in step block 306, the first reaction data and the second reaction data are compared to determine the status of the special components of the blood. Here, the microfluidic biochip detection device used is composed of the blood reagent unit and the biochip unit described in the above paragraph connected to each other in a detachable manner, so the relevant hardware details and changes can be omitted and not repeated.

[0037] Obviously, compared with the common design of using existing commercial microfluidic biochip detection devices, the main feature of the method proposed by the present invention is that step block 301 and step block 302 flexibly select blood reagent units with corresponding reagents and biochip units of corresponding biochips to assemble the microfluidic biochip detection device to be used according to the blood samples to be detected and how the blood samples need to be detected. That is to say, before testing a batch of blood, the corresponding blood reagent unit and biochip unit can be selected according to the special components of the blood to be tested. That is to say, after testing the previous batch of blood and before testing the next batch of blood, if the first special component to be detected in the previous batch of blood is different from the second special component to be detected in the second batch of blood, the corresponding blood reagent unit and biochip unit can be selected according to the second special component of the second batch of blood. FIG. 3B to FIG. 3DThe method flow is briefly described, firstly, a plurality of different blood reagent units 331-339 with different reagents (3301-3309) and a plurality of different biochip units 341-349 with different biochips (3401-3409) are provided. Then, when it is necessary to detect a first component in a first blood sample, a blood reagent unit 332 with a reagent 3302 and a biochip unit 342 with a biochip 3402 are selected to assemble into a microfluidic biochip detection device to be used. Next, when it is necessary to detect a second component in a second blood sample, a blood reagent unit 337 with a reagent 3307 and a biochip unit 347 with a biochip 3407 are selected to assemble into a microfluidic biochip detection device to be used. After the two selected units are assembled into a microfluidic biochip detection device, a special detection liquid can be input into the biochip unit, blood can be input into the blood reagent unit, and a special detection liquid can be input into the biochip unit in sequence, and then the first reaction data and the second reaction data obtained respectively can be compared to determine the status of the second special component. How to obtain the blood test result from the sequential reaction between the biochip and the test liquid / blood can be achieved using commercial biochips, etc., and will not be described again here.

[0038] In summary, according to the description in the above embodiments, the present invention may have many modifications and differences. Therefore, it should be understood within the scope of the additional claims. In addition to the above detailed description, the present invention can also be widely implemented in other embodiments. The above is only a preferred embodiment of the present invention and is not intended to limit the scope of the patent application of the present invention; any other equivalent changes or modifications that are completed without departing from the spirit disclosed by the present invention should be included in the scope of the following patent application.

Claims

1. A microfluidic biochip detection device, comprising: A blood reagent unit, which has at least a first microfluidic channel, through which the blood to be tested flows; as well as A biochip unit, which at least has a second microchannel, a third microchannel and a biochip, wherein the blood from the first microchannel of the blood reagent unit flows through the second microchannel to reach the biochip, and the detection liquid flows through the third microchannel to reach the biochip; Wherein, at least one reagent is located in the first microchannel to react with a component of the blood flowing through; Wherein, the second microchannel and the third microchannel are separated from each other, so that the blood and the detection liquid flow to the biochip respectively; Wherein, the blood reagent unit and the biochip unit are detachably connected to each other.

2. The microfluidic biochip detection device according to claim 1, wherein: A blood reagent unit further comprising a first opening and a second opening, wherein the blood entering from the first opening first flows through the first microchannel and then flows out from the second opening; as well as The biochip unit further has a third opening and a fourth opening. The blood from the blood reagent unit enters the second microchannel from the third opening, and the detection liquid enters the third microchannel from the fourth opening.

3. The microfluidic biochip detection device according to claim 2, wherein: When the blood reagent unit and the biochip unit are connected to each other, the second opening of the blood reagent unit is connected to the third opening of the biochip unit, so that blood will not leak outside the blood reagent unit and the biochip unit during the process of flowing from the blood reagent unit to the biochip unit.

4. The microfluidic biochip detection device according to claim 2, wherein: The second opening is adjacent to the third opening, the first opening and the fourth opening are located on the same side of the microfluidic biochip detection device, and the first opening and the fourth opening are located on opposite sides of the microfluidic biochip detection device with the biochip.

5. The microfluidic biochip detection device according to claim 2, further comprising at least one of the following: A portion of the first microfluidic channel has a reagent for reacting with a component of blood; Different parts of the first microfluidic channel have different reagents for reacting differently with certain components of the blood; and Different parts of the first microfluidic channel have different reagents for reacting differently with different components of the blood.

6. The microfluidic biochip detection device according to claim 5, further comprising at least one of the following: At least one reagent is coated on the first microfluidic channel; and The types of reagents include: Separating agent, erythrocyte precipitant, leukocyte precipitant, activated carbon and silver nitrate.

7. The microfluidic biochip detection device according to claim 2, further comprising at least one of the following: A first filter, located at the first opening, for filtering impurities in the blood; and The second filter is located between the second opening and the third opening and is used to filter impurities in the blood.

8. The microfluidic biochip detection device according to claim 5, wherein: The blood reagent unit is a double-layer structure consisting of a first layer and a second layer arranged in sequence, wherein the first opening is located in the first layer, and the second opening and the first microchannel are located in the second layer.

9. The microfluidic biochip detection device according to claim 5, wherein: The blood reagent unit is a three-layer structure consisting of a first layer, a third layer and a fourth layer arranged in sequence, wherein the first opening is located in the first layer, the second opening is located in the third layer, and the first microchannel is located in the third layer and the fourth layer.

10. The microfluidic biochip detection device according to claim 5, wherein: The blood reagent unit is a three-layer structure consisting of a first layer, a third layer and a fourth layer arranged in sequence, wherein the first opening is located on the first layer, the second opening is located on the third layer, and the first microchannel is located on the fourth layer. The third layer further includes a first groove and a second groove, and the first microfluidic channel is connected to the first groove and the second groove respectively, so that at least one reagent is located in a portion of the first microfluidic channel between the first groove and the second groove.

11. The microfluidic biochip detection device according to claim 2, wherein: The biochip unit is a double-layer structure consisting of a fifth layer and a sixth layer arranged in sequence, wherein the fourth opening is located on the fifth layer, the third opening is located on the sixth layer, the second microchannel and the third microchannel are both located on the sixth layer, and the biochip is located at the bottom of the sixth layer.

12. The microfluidic biochip detection device according to claim 2, wherein: The biochip unit is a three-layer structure consisting of a fifth layer, a seventh layer and an eighth layer arranged in sequence, wherein the fourth opening is located on the fifth layer, the third opening is located on the seventh layer, the second microchannel is located on the seventh layer, the third microchannel is located on the eighth layer, and the biochip is located at the bottom of the eighth layer.

13. The microfluidic biochip detection device according to claim 2, wherein: The biochip unit is a three-layer structure consisting of a fifth layer, a seventh layer and an eighth layer arranged in sequence, wherein the fourth opening is located on the fifth layer, the third opening is located on the seventh layer, the second microchannel is located on the seventh layer, the third microchannel is located on the eighth layer and passes through the third groove on the eighth layer before reaching the top of the biochip, and the biochip is located at the bottom of the eighth layer.

14. The microfluidic biochip detection device according to claim 2, wherein: The blood reagent unit further includes a first gas opening and a first gas microchannel. The gas entering from the first gas opening flows through the first gas microchannel and enters the first microchannel, thereby promoting the flow of blood.

15. The microfluidic biochip detection device according to claim 2, wherein: The biochip unit further includes a second gas opening and a second gas microchannel. The gas entering from the second gas opening flows through the second gas microchannel and enters the third microchannel, thereby promoting the flow of the detection liquid.

16. The microfluidic biochip detection device according to claim 2, wherein: The bottom of the biochip unit also includes a waste liquid tank and a waste liquid discharge hole. The waste liquid tank is connected to the biochip to temporarily store the blood and detection liquid flowing through the biochip, and the waste liquid discharge hole is connected to the waste liquid tank to discharge the blood and detection liquid from the waste liquid tank.

17. A method for detecting blood using a microfluidic biochip detection device, comprising: Determine the special reagents, special test fluids and special biochips to be used based on the special components of the blood to be tested; Providing microfluidic biochip detection devices with special reagents and special biochips; Inputting a special detection liquid into the microfluidic biochip detection device to obtain first reaction data between the special detection liquid and the special biochip; Blood is input into the microfluidic biochip detection device, so that the special biochip interacts with the blood treated with a special reagent to change the state of the special biochip; Inputting the special detection liquid into the microfluidic biochip detection device again to obtain second reaction data between the special detection liquid and the special biochip with a changed state; and Comparing the first reaction data with the second reaction data to determine the status of the special component of the blood; The microfluidic biochip detection device comprises a blood reagent unit and a biochip unit, wherein the blood reagent unit comprises a first microfluidic channel and a special reagent located in the first microfluidic channel, and the biochip unit comprises a biochip and a second microfluidic channel and a third microfluidic channel separated from each other, the blood input into the blood reagent unit flows through the first microfluidic channel and the second microfluidic channel successively and arrives at the biochip after being treated by the special reagent, and the detection liquid input into the biochip unit flows through the third microfluidic channel and arrives at the biochip; Wherein, the blood reagent unit and the biochip unit are connected to each other in a detachable manner.

18. The method according to claim 17, wherein: After testing the previous batch of blood and before testing the next batch of blood, if the first special component to be detected in the previous batch of blood is different from the second special component to be detected in the second batch of blood, first select the corresponding blood reagent unit and biochip unit according to the second special component of the second batch of blood and assemble them into the microfluidic biochip detection device, then input the special detection liquid into the biochip unit, input blood into the blood reagent unit, and input the special detection liquid into the biochip unit in sequence, and then compare the first reaction data and the second reaction data obtained to determine the status of the second special component.

19. The method according to claim 17, wherein: The blood reagent unit has a first opening, a second opening and a first microfluidic channel. The blood entering from the first opening will first flow through the first microfluidic channel and then flow out from the second opening. The biochip unit has a third opening, a fourth opening, a second microfluidic channel, a third microfluidic channel and a biochip. The blood from the blood reagent unit entering from the third opening will flow through the second microfluidic channel to reach the biochip, and the test liquid entering from the fourth opening will flow through the third microfluidic channel to reach the biochip. Here, the second microfluidic channel and the third microfluidic channel are separated from each other, so that the blood and the test liquid flow to the biochip separately.

20. The method of claim 17, further comprising at least one of the following: At least one reagent is coated on the first microfluidic channel; and The types of reagents include: Separating agent, erythrocyte precipitant, leukocyte precipitant, activated carbon and silver nitrate.